Patient Preferences for Symptom-Driven or Regular Preventer Treatment in Mild to Moderate Asthma: Findings From the PRACTICAL Study, a Randomised Clinical Trial

Abstract

C Baggott, HK Reddel, J Hardy. Eur Respir J. 2020;55(4):1902073 Symptom-driven low-dose inhaled corticosteroid–formoterol use is safe and effective in mild asthma and has been recommended as one of the preferred treatment regimens at steps 1 and 2 in the 2019 update of the Global Initiative for Asthma (GINA). However, there are no data on patient preferences for this regimen. The purpose of this study was to investigate patient preferences between two regimens: symptom-driven budesonide-formoterol versus maintenance inhaled corticosteroid (ICS) with a separate as-needed reliever inhaler. This study …